Loading…
Loading…
Tender Value
₹15.7 L
EMD Value
₹78,500
Closing Date
14 Oct 2026, 6:00 pm
THE COMMANDANT ARMY HOSPITAL R AND R
THE COMMANDANT ARMY HOSPITAL R AND R DELHI CANTT
2433/MS/EXP/D-290/1597, 290/836/Med Store, Dept of Main OT (Drugs)/IFA RE 180/2026-27 FOR AHRR
2026_ARMY_790898_1
2433/MS/EXP/D-290/1597, 290/836/Med Store, Dept of Main OT (Drugs)/IFA RE 180/2026-27
Open Tender
Medical Equipments/Waste
Buy
ARMY HOSPITAL R AND R DELHI CANTT
Please refer Tender documents.
2 documents required · 2 mandatory
₹0
₹78,500
Yes
24 Sept 2026
24 Sept 2026
15 Oct 2026
24 Sept 2026
14 Oct 2026
24 Sept 2026
24 Sept 2026 - 14 Oct 2026
| Sl No | Description | Qty | Unit | Est. Rate | Est. Amount |
|---|---|---|---|---|---|
| 1Med Store & Dept of Main OT | |||||
| 1.01 | Inj Ropivacaine, 0.2% amp of 10 ml | 600 | AMP | - | - |
| 2.01 | Inj Dexmedetomidine 100mcg/ml | 9,800 | AMP | - | - |
| 3.01 | Succinylchloline Chloride 50 mg/ml, 2 ml Inj | 2,650 | AMP | - | - |
| 4.01 | Phenylephrine 50 mcg/ml inj in 10 ml vial | 600 | VIAL | - | - |
| 5.01 | Inj Rocuronium Bromide 10mg/ml, Vial of 10ml | 1,700 | VIAL | - | - |
| 6.01 | Frusemide 20mg/ml 2ml Inj | 44,400 | AMP | - | - |
| 7.01 | Methyl Prednisolone Sodium Acetate 80 mg Inj Intra articular (Depo Medrol) | 1,000 | VIAL | - | - |
| 8.01 | Diclofenac Suppositories 25 mg | 13,200 | No | - | - |
| 9.01 | Isoprenaline HCl 200 mcg/ml, 1 ml Inj | 830 | AMP | - | - |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.03 MB
Tendernotice_1.pdf
PDF • 0.59 MB
RFP.pdf
Tender Documents • 1.32 MB
BOQ_886649.xls
BOQ • 0.81 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .